Gentamicin in the treatment of sepsis in newborn infants.
D001238:Asphyxia Neonatorum / Q000150:complications; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000009:adverse effects / Q000627:therapeutic use*; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007003:Hypoglycemia / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D010019:Osteomyelitis / Q000150:complications; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012189:Retrospective Studies; D018805:Sepsis / Q000150:complications / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013997:Time Factors
D005839:Gentamicins